Issue 44, 2023

A metal–organic framework complex for enhancing tumor treatments through synergistic effect of chemotherapy and photodynamic therapy

Abstract

Porphyrin-based metal–organic frameworks (PMOFs) are a kind of crystal hybrid material with broad application prospects in energy, catalysis, biomedicine, and other fields. In this study, the La-TCPP PMOF nanocrystal was constructed using a porphyrin ligand and La ion. This material can produce a high loading rate on doxorubicin (DOX) owing to its special porous structure. The high loading rate of drug molecules and the reactive oxygen species (ROS) of the porphyrin ligand enable La-TCPP@DOX nanocrystal to produce a powerful killing effect on cancer cells under the synergistic attack of chemotherapy (CT) and photodynamic therapy (PDT). Finally, by modifying the targeted aptamer, the actual therapeutic effect of this special La-TCPP@DOX@Apt material on tumors was confirmed by applying the established mouse tumor model. The composite nanomaterial not only avoids the side effects caused by high concentrations of chemotherapeutic drugs, but also overcomes the limitation of PDT owing to insufficient light penetration and can inhibit and kill solid tumors under the condition of synergistic attack. This study is a complement to PMOF crystal materials, and its tumor-killing ability was achieved by loading drugs and introducing targeting molecules, which proves that the synergistic attack can more effectively inhibit and treat solid tumors. These studies have a reference and guiding significance for the treatment of cancer patients.

Graphical abstract: A metal–organic framework complex for enhancing tumor treatments through synergistic effect of chemotherapy and photodynamic therapy

Supplementary files

Article information

Article type
Paper
Submitted
15 jul 2023
Accepted
21 out 2023
First published
23 out 2023

J. Mater. Chem. B, 2023,11, 10706-10716

A metal–organic framework complex for enhancing tumor treatments through synergistic effect of chemotherapy and photodynamic therapy

X. Jiang, Y. Zhao, S. Sun, L. Wang, L. Sun, W. Li, Z. Wang, J. Wang and R. Pei, J. Mater. Chem. B, 2023, 11, 10706 DOI: 10.1039/D3TB01592K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements